Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants

Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(3):468–474

Cheungpasitporn W, Thongprayoon C, Mao MA et al (2014) The risk of coronary heart disease in patients with kidney stones: a systematic review and meta-analysis. N Am J Med Sci 6(11):580–585

National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266

Chen N, Wang W, Huang Y et al (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24(7):2117–2123

Ingsathit A, Thakkinstian A, Chaiprasert A et al (2010) Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant 25(5):1567–1575

Vupputuri S, Soucie JM, McClellan W et al (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14(3):222–228

Marangella M, Bruno M, Cosseddu D et al (1990) Prevalence of chronic renal insufficiency in the course of idiopathic recurrent calcium stone disease: risk factors and patterns of progression. Nephron 4(4):302–306

Hippisley-Cox J, Coupland C (2010) Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 21(11):49

Kummer AE, Grams M, Lutsey P et al (2015) Nephrolithiasis as a risk factor for CKD: the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 10(11):2023–2029

Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269

Bekkering GE, Harris RJ, Thomas S et al (2008) How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol 167(9):1017–1026

Wells GA, Shea B, O’Connell D et al (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed Dec 2014

Aune D, Lau R, Chan DSM et al (2011) Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 141(1):16–20

Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration, 5.1.0 edn. http://www.cochrane-handbook.org . Accessed 23 May 2016

Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

Rule AD, Bergstralh EJ, Melton LJ et al (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4(4):804–811

El-Zoghby ZM, Lieske JC, Foley RN et al (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol 7(9):1409–1415

Shoag J, Halpern J, Goldfarb DS et al (2014) Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol 192(5):1440–1445

Alexander RT, Hemmelgarn BR, Wiebe N et al (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287

D’Costa M, Savcic-Kos R, Huang J et al (2016) Urological procedures in urolithiasis and their association with chronic kidney disease. Clin Med Res 14(2):75–82

Keller JJ, Chen YK, Lin HC (2012) Association between chronic kidney disease and urinary calculus by stone location: a population-based study. BJU Int 110(11 Pt C):E1074–E1078

Ando R, Nagaya T, Suzuki S et al (2014) MP34-15 increased risk for chronic kidney disease in kidney stone formers: a follow-up study in Japanese. Urolithiasis 6(42):498

Pearle MS, Goldfarb DS, Assimos DG et al (2014) Medical management of kidney stones: AUA guideline. J Urol 192(2):316–324

Türk C, Petřík A, Sarica K et al (2016) EAU guidelines on interventional treatment for urolithiasis. Eur Urol 69(3):475–482

Lieske JC, Peña de la Vega LS, Slezak JM et al (2006) Renal stone epidemiology in Rochester, Minnesota: an update. Kidney Int 69(4):760–764

Zhang L, Wang F, Wang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815–822